NCT00876382View on ClinicalTrials.gov

Community Oncology Setting Disease Outcomes of Sorafenib (Nexavar) Use in Advanced Renal Cell Carcinoma

CompletedOBSERVATIONAL
Enrollment

47

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

February 28, 2011

Study Completion Date

August 31, 2011

Conditions
Renal Cell Carcinoma
Trial Locations (8)

30901

Medical Oncology Associates of Augusta, Augusta

33705

Gulfcoast Oncology Associates, St. Petersburg

37023

Tennessee Oncology, PLLC, Nashville

39202

Jackson Oncology Associates, Jackson

40207

Consultants in Blood Disorders and Cancer, Louisville

45242

Oncology Hematology Care, Cincinnati

63017

St. Louis Cancer Care, Chesterfield

72401

Northeast Arkansas Clinic, Jonesboro

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

SCRI Development Innovations, LLC

OTHER